Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$349M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$305M |
| 3 |
iShares Gold Trust
IAU
|
+$282M |
| 4 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$269M |
| 5 |
Blackrock
BLK
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$625M |
| 2 |
NVIDIA
NVDA
|
+$604M |
| 3 |
Tesla
TSLA
|
+$576M |
| 4 |
Microsoft
MSFT
|
+$552M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.55% |
| 2 | Financials | 7.82% |
| 3 | Consumer Discretionary | 7.65% |
| 4 | Communication Services | 5.12% |
| 5 | Healthcare | 5.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Lithia Motors
LAD
$8.32B
| $2.17M | ﹤0.01% |
6,426
-1,611
| -20% | -$498K |
|
2502
Rhythm Pharmaceuticals
RYTM
$7.99B
| $2.17M | ﹤0.01% |
34,324
-51,882
| -60% | -$3.18M |
|
2503
Interparfums
IPAR
$3.7B
| $2.16M | ﹤0.01% |
16,465
-10,166
| -38% | -$1.24M |
|
2504
CALL
DHT Holdings
DHT
$3.09B
| $2.16M | ﹤0.01% |
+200,000
| New | +$2.2M |
|
2505
Dutch Bros
BROS
$8.93B
| $2.16M | ﹤0.01% |
31,599
+3,578
| +13% | +$233K |
|
2506
Core & Main
CNM
$8.64B
| $2.16M | ﹤0.01% |
35,754
-9,671
| -21% | -$517K |
|
2507
Herc Holdings
HRI
$5.64B
| $2.15M | ﹤0.01% |
16,331
-14,524
| -47% | -$1.76M |
|
2508
Virtus Investment Partners
VRTS
$1.14B
| $2.15M | ﹤0.01% |
11,852
+1,886
| +19% | +$314K |
|
2509
Envista
NVST
$4.51B
| $2.15M | ﹤0.01% |
109,987
-24,076
| -18% | -$419K |
|
2510
CALL
DraftKings
DKNG
$12.6B
| $2.14M | ﹤0.01% |
+50,000
| New | +$1.79M |
|
2511
PUT
Baidu
BIDU
$35.5B
| $2.14M | ﹤0.01% |
25,000
-25,000
| -50% | -$2.16M |
|
|
XHR
2512
Xenia Hotels & Resorts
XHR
$1.76B
| $2.14M | ﹤0.01% |
170,172
-20,077
| -11% | -$230K |
|
|
SLNO
2513
DELISTED
Soleno Therapeutics
SLNO
| $2.13M | ﹤0.01% |
25,467
-29,651
| -54% | -$2.22M |
|
2514
Veracyte
VCYT
$3.42B
| $2.13M | ﹤0.01% |
78,913
-75,718
| -49% | -$2.19M |
|
2515
Fate Therapeutics
FATE
$294M
| $2.13M | ﹤0.01% |
1,903,738
-33,395
| -2% | -$38.8K |
|
|
SFD
2516
Smithfield Foods
SFD
$8.85B
| $2.13M | ﹤0.01% |
90,514
+89,544
| +9,231% | +$1.98M |
|
2517
B&G Foods
BGS
$299M
| $2.13M | ﹤0.01% |
502,783
+388,470
| +340% | +$2.03M |
|
2518
Westamerica Bancorp
WABC
$1.39B
| $2.13M | ﹤0.01% |
43,872
-4,897
| -10% | -$235K |
|
|
ETNB
2519
DELISTED
89bio
ETNB
| $2.12M | ﹤0.01% |
216,325
+9,195
| +4% | +$76.1K |
|
2520
Ryder
R
$10.1B
| $2.12M | ﹤0.01% |
13,354
+2,556
| +24% | +$376K |
|
2521
PUT
CSX Corp
CSX
$92.9B
| $2.12M | ﹤0.01% |
65,000
-540,500
| -89% | -$16.3M |
|
|
FLG
2522
CALL
Flagstar Bank National Association
FLG
$5.92B
| $2.12M | ﹤0.01% |
200,000
| – | – |
|
2523
Evolent Health
EVH
$527M
| $2.12M | ﹤0.01% |
188,229
-331,530
| -64% | -$3.04M |
|
2524
BlackBerry
BB
$5.27B
| $2.12M | ﹤0.01% |
461,672
+85,878
| +23% | +$324K |
|
2525
Fastly Inc
FSLY
$4.78B
| $2.12M | ﹤0.01% |
299,951
-22,850
| -7% | -$153K |
|
Similar funds
Citigroup's Q2 2025 Portfolio in Review
As of Q2 2025, Citigroup held 6,003 positions worth $204B, up 4.1% from $196B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup withdrew a net $14.6B in Q2 2025, closing 377 positions and reducing 2,974 holdings. Its most notable exit was James Hardie Industries, an estimated $125M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citigroup opened a new position in Amrize Ltd worth $114M.
- Citigroup's largest Q2 2025 buy was Amrize Ltd: 2,294,135 shares worth $114M.
- Citigroup added most to Bank of America in Q2 2025, an estimated $349M increase.
- Citigroup's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $625M.
- Citigroup fully exited James Hardie Industries in Q2 2025, selling an estimated $125M.
- Citigroup's ten largest holdings make up 20% of its $204B portfolio in Q2 2025.
- Citigroup opened 468 new positions and closed 377 in Q2 2025.
- Citigroup's portfolio value rose 4.1% quarter-over-quarter to $204B.
Based on Citigroup's 13F filing for Q2 2025, filed 11 Aug 2025.